Relevant bibliographies by topics / Hydergine

Academic literature on the topic 'Hydergine'

Author: Grafiati
Published: 26 July 2024
Last updated: 28 July 2024

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Contents

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Hydergine.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Hydergine"

1

Nussenblatt, RobertB, HowardA Austin, AlanG Palestine, and HarryG Preuss. "HYDERGINE AND CYCLOSPORIN NEPHROTOXICITY." Lancet 327, no. 8491 (May 1986): 1220–21. http://dx.doi.org/10.1016/s0140-6736(86)91209-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

TAMURA, TAKASHI, TAIICHI SATOH, HISANORI MINAKAMI, and TARO TAMADA. "Effect of Hydergine in Hyperprolactinemia." Journal of Clinical Endocrinology & Metabolism 69, no. 2 (August 1989): 470–74. http://dx.doi.org/10.1210/jcem-69-2-470.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Guida, Charles V. "Review: Hydergine is effective for dementia." ACP Journal Club 122, no. 1 (January 1, 1995): 17. http://dx.doi.org/10.7326/acpjc-1995-122-1-017.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Kho, T. L., R. Kengen, K. M. L. Leunissen, J. Teule, and J. P. Van Hooff. "HYDERGINE AND REVERSIBILITY OF CYCLOSPORIN NEPHROTOXICITY." Lancet 328, no. 8503 (August 1986): 394–95. http://dx.doi.org/10.1016/s0140-6736(86)90077-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

&NA;. "Hydergine-LC appears ineffective in Alzheimer's disease." Inpharma Weekly &NA;, no. 751 (August 1990): 9–10. http://dx.doi.org/10.2165/00128413-199007510-00027.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Romero, R., A. Felip, J. M. Llibre, J. Bonet, and A. Caralps. "Co-Dergocrine Mesylate (Hydergine) and Hypertensive Emergencies." Nephron 51, no. 1 (1989): 127–28. http://dx.doi.org/10.1159/000185270.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Schneider, L. S., and J. T. Olin. "Overview of Clinical Trials of Hydergine in Dementia." Archives of Neurology 51, no. 8 (August 1, 1994): 787–98. http://dx.doi.org/10.1001/archneur.1994.00540200063018.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Kuskowski, Michael A., Gerald Morley, Stephen M. Malone, Maurice W. Dysken, and Amy Okaya. "Hydergine Treatment and Psychophysiological Measures in Primary Degenerative Dementia." Journal of Geriatric Psychiatry and Neurology 3, no. 1 (January 1990): 41–47. http://dx.doi.org/10.1177/089198879000300109.

Full text
Abstract:
Changes in smooth pursuit eye movements and the P300 component of the auditory evoked potential were studied in patients with primary degenerative dementia during a double-blind, placebo-controlled study of ergoloid mesylates (Hydergine). After 18 weeks of treatment, P300 latency and amplitude, recorded at three scalp electrode sites, had not changed significantly. Smooth pursuit gain was elevated for the drug group under some stimulus conditions, suggesting a normalization of pursuit eye movement functioning. However, the results of several other measures of the quality of pursuit eye movements failed to corroborate this finding. ( J Geriatr Psychiatry Neurol 1990; 3:41-47).
APA, Harvard, Vancouver, ISO, and other styles
9

Sobky, A. El, M. El Shazly, A. K. Darwish, T. Davies, K. Griffin, and M. S. Keshavan. "Hydergine effect on prolactin and reaction time in dementia." Biological Psychiatry 21, no. 12 (October 1986): 1229–30. http://dx.doi.org/10.1016/0006-3223(86)90230-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Lon, S., M. D. Schneider, T. Jason, and A. M. Olin. "Meta-analysis of hydergine clinical trials in primary dementia." Neurobiology of Aging 13 (January 1992): S123. http://dx.doi.org/10.1016/0197-4580(92)90613-3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Hydergine"

1

Weil, Claude. Hydergine ®. Berlin, Heidelberg: Springer Berlin Heidelberg, 1988. http://dx.doi.org/10.1007/978-3-642-73702-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Weil, Claude. Hydergin ®. Berlin, Heidelberg: Springer Berlin Heidelberg, 1989. http://dx.doi.org/10.1007/978-3-662-12032-3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Hydergine R. Springer-Verlag Berlin and Heidelberg GmbH & Co. K, 1988.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Hydergine(r). Island Press, 1988.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Weil, Claude. Hydergine: Pharmacologic and Clinical Facts. Springer, 1988.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Weil, Claude. Hydergine ®: Pharmacologic and Clinical Facts. Springer London, Limited, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Weil, Claude. Hydergine®: Pharmacologic and Clinical Facts. Springer, 2011.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Weil, Claude. Hydergin®: Pharmakologische und Klinische Befunde. Springer London, Limited, 2013.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Schild, H. O., C. Weil, U. Mittmann, and B. Berde. Pharmakologie und Klinische Pharmakologie Von Hydergin®. Springer London, Limited, 2013.

Find full text
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Hydergine"

1

Weil, Claude. "Introduction and Background Information." In Hydergine ®, 1–4. Berlin, Heidelberg: Springer Berlin Heidelberg, 1988. http://dx.doi.org/10.1007/978-3-642-73702-2_1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Weil, Claude. "Basic Pharmacologic Properties: Peripheral Effects on Neurotransmission." In Hydergine ®, 5–11. Berlin, Heidelberg: Springer Berlin Heidelberg, 1988. http://dx.doi.org/10.1007/978-3-642-73702-2_2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Weil, Claude. "Basic Pharmacologic Properties: Central Effects." In Hydergine ®, 13–52. Berlin, Heidelberg: Springer Berlin Heidelberg, 1988. http://dx.doi.org/10.1007/978-3-642-73702-2_3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Weil, Claude. "Effects of Co-Dergocrine on the Cardiovascular System." In Hydergine ®, 53–60. Berlin, Heidelberg: Springer Berlin Heidelberg, 1988. http://dx.doi.org/10.1007/978-3-642-73702-2_4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Weil, Claude. "Effects of Co-Dergocrine on Other Organs and Cells." In Hydergine ®, 61–64. Berlin, Heidelberg: Springer Berlin Heidelberg, 1988. http://dx.doi.org/10.1007/978-3-642-73702-2_5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Weil, Claude. "The Clinical Pharmacology of Co-Dergocrine in Age-Related Cerebral Insufficiency." In Hydergine ®, 65–86. Berlin, Heidelberg: Springer Berlin Heidelberg, 1988. http://dx.doi.org/10.1007/978-3-642-73702-2_6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Weil, Claude. "Co-Dergocrine in Various Cardiovascular and Cerebral Indications." In Hydergine ®, 87–90. Berlin, Heidelberg: Springer Berlin Heidelberg, 1988. http://dx.doi.org/10.1007/978-3-642-73702-2_7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Weil, Claude. "Biopharmaceutical Aspects." In Hydergine ®, 91–93. Berlin, Heidelberg: Springer Berlin Heidelberg, 1988. http://dx.doi.org/10.1007/978-3-642-73702-2_8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Weil, Claude. "Toxicologic Considerations." In Hydergine ®, 95–97. Berlin, Heidelberg: Springer Berlin Heidelberg, 1988. http://dx.doi.org/10.1007/978-3-642-73702-2_9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Markstein, Rudolf. "Hydergine: Interaction with Neurotransmitter Systems in the Central Nervous System." In Aging 2000: Our Health Care Destiny, 361–75. New York, NY: Springer New York, 1985. http://dx.doi.org/10.1007/978-1-4612-5058-6_30.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Hydergine' for particular source types:
Journal articles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography